Objective: To present our innovative limboconjunctival flap technique in the surgical treatment of primary pterygium and evaluate its effectiveness and safety.
INTRODUCTION
A pterygium is a triangular tissue situated in the interpalpebral region; its cap is on the cornea side, and it consists of three partsa body connected to the bulbar conjunctiva, a head that is advancing over the cornea, and the cap (1) .
Although the etiopathogenesis of pterygium is not precisely known, many scientists believe that solar ultraviolet (UV) radiation is responsible for the development and progression of pterygium. Other factors that are blamed in the pathogenesis of pterygium are heat, micro traumas due to dust particles, a dry atmosphere, viral infections, immunological mechanisms, extracellular matrix remodeling, growth factors, some cytokines, antiapoptotic mechanisms, and a few angiogenic factors (2) (3) (4) .
Because of the hyperplasia that occurs in the damaged limbal cells of those exposed to UV radiation, limbus tissue is perceived by the body as a foreign object, and chronic inflammation develops against this as a hypersensitivity reaction. This chronic inflammation, in turn, causes vascularization (5, 6) .
The treatment of pterygium is symptomatic until a surgical indication is set. The definitive treatment after pterygium occurs is surgery (7) (8) . Desmarres stated in 1855 that after a pterygium was separated, it was transplanted by suturing to the fornix and then it underwent atrophy. This transplantation application of Desmarres pioneered all subsequent transplantation techniques developed to date (9) . One of the main goals of a successful pterygium surgery is to avoid relapse. To date, many surgical approaches have been presented to find ways to cope with relapse. In recent years, conjunctival flaps and autografts have been generally preferred because of their higher success rates. Relapse rates are reported as 0-31% in conjunctival flaps and only 0-14.6% in autografts (7, 8) . A limboconjunctival autograft is used in pterygium surgery with the aim to induce contact inhibition in abnormal residual tissue, to rearrange the limbal barrier with transplanted healthy limbal cells, and to construct a barrier against the invasion of the cornea by conjunctiva by preventing fibrosis (9) . We developed this new flap technique to obtain an answer to the question of whether we can also establish this mechanism exactly in limboconjunctival flaps. In this study, we aimed to introduce the limboconjunctival flap technique that we newly developed for the surgical treatment of primary pterygium and to evaluate its efficiency and safety.
METHODS
Thirty-three eyes of 32 patients who were diagnosed with primer pterygium were retrospectively evaluated. Cases that had prier pterygium displaying 3 mm or more penetration into the cornea were included in the study. Cases with relapse pterygium, double-headed pterygium, and a suspicion of malignancy as well as cases with ocular surface disease and cases with less than 3 months follow-up were excluded from the study. Prior to the operation, the visual acuity of each patient was measured on a Snellen chart. Extension of pterygium onto the cornea was evaluated by conducting biomicroscopic evaluations. Intraocular pressure measurements were conducted by Goldman applanation tonometry. Preoperative symptoms of the cases were asked, recorded, and a scoring system was established by adding the number of symptoms present for each patient. This scoring is shown in Table 1 .
Surgical Technique
A lip retractor was placed following appropriate surgical site cleaning. Topical proparacaine was dripped, and local anesthesia was established by lidocaine 20 mg/mL + epinephrine HCl 0.0125 mg/mL via a subconjunctival 26 G needle. The conjunctiva and pterygium tissue were separated. Pterygium on the cornea surface was cleaned with a crescent knife. After performing pterygium excision on the patients, hemostasis was achieved on the scleral bed with monopolar cautery. Lidocaine 20 mg/mL + epinephrine HCl 0.0125 mg/mL were administered to the subconjunctival area via a 26 G needle to ease the dissection in the upper nasal quadrant of the same eye. The limbus side of the scleral aperture was measured with the help of a Castroviejo caliper. A limboconjunctival flap large enough to cover the scleral aperture was separated from the tenon by performing a blunt dissection in the adjacent upper nasal area. The rectangular flap was thus prepared; its base being on the fornix. The limboconjunctival flap, prepared from the upper nasal conjunctiva adjacent to the excision area, was slid onto the scleral bed. The limbal lower corner of the flap was episclerally sutured to the lower limbus of the excision area. The upper corner of the flap was fixed to the upper limbus of the scleral aperture by a second episcleral suture. It was also fixed to the lower edge of the flap by a third episcleral suture. It was ensured that the limboconjunctival area of the flap corresponded to the limbus in the excision area. Suturation was not performed to the area that the flap was taken from (Figure 1 ). The sutures were removed from the cases in the 2 nd week. They were controlled on the 1 st day, 1 st week, 2 nd week, 1st month, and then monthly. After the surgery, the eyes were shut until the corneas were epithelized. Postoperative topical antibiotic ofloxacin 5 × 1 was used. Topical steroid prednisolone acetate 4 × 1 was administered. Topical prednisolone acetate treatment was stopped on the second week to avoid its side effects such as glaucoma and cataract, and instead, a fluorometholone group steroid drip 4 × 1 was used for 2 months. A synthetic tear polyvinyl alcohol + povidone drip 5 × 1 and a synthetic tear gel carbomer 1 × 1 were used for 6 months.
In the controls, vision evaluation via a Snellen chart, biomicroscopic examinations, and intraocular pressure via Goldman applanation tonometry (GAT) were measured. The symptoms and complaints of patients were inquired again in the same way as they were prior to the operation, and their numbers were noted and a complaint score was formed after the operation.
Radial veins 1 mm or above in the paracentral area of the cornea was accepted as a sign of a relapse. Postoperative complications and relapse developments were recorded. Relapse cases were accepted as a failure.
RESULTS
Thirty-three eyes of 32 patients were included in the study. Fifteen of the patients (46.87%) were male and 17 (53.13%) were female. The average age of the cases was 47.9 (42-69) years. When pterygium laterality was viewed, 15 patients had pterygium on the right eye, 18 on the left eye, and 1 had bilateral pterygium (Table 2) .
On an average, 7.2 months (3-11 months) of postoperative follow-up was performed. No intraoperative complications were observed. The cornea epithelial defect was observed to close within a week in all cases. Avascular flap and dellen complications were not observed in any of the cases (Figure 2, 3) . The flap was observed to cling on to the scleral bed in the 1st postoperative week. Thirty-one cases were successful (93.9%), while the flap was observed to slide 0.5 mm onto the cornea in two cases. In these cases, the edge of the flap that slid onto the cornea was excised. In one case, granulation tissue formation was observed in the border of the graft, and it was excised. Acute inflammatory development was observed in the pathological diagnosis of the case. A relapse was not observed in our 3-month follow-up of this case.
A relapse was observed in two cases (6.1%). The relapse was detected in the 2 nd month in one of these cases and in the 3rd month in the other case. Pterygium excision and limboconjunctival autograft were performed on these cases 6 months after the initial surgery. A relapse was not observed in the, on an average, 4-month follow-up of these cases. When the postoperative complaint scoring is viewed, a significant decrease in complaints can be observed compared with the preoperative complaints (p<0.05).
DISCUSSION
Although extremely different surgical approaches are presented and the present methods have been improved to find ways to cope with relapse, success in this area is still limited (1).
With the conjunctival flap technique, which is one of the techniques studied, one attempts to establish a healthy conjunctiva by sliding the flaps or pedunculated flaps from the surrounding tissue. The standard technique of pterygium transplantation began with the technique of McReynolds. In this technique, the excised pterygium is sutured to the lower subconjunctival area, and the remaining conjunctival aperture is sutured with a 4/0 silk suture. In Neher's technique, however, the head of the pterygium is embedded to the superior and sutured to the episclera. Knapp's technique is generally used in very wide pterygia. Knapp peeled pterygium from the cornea, bisected it with a horizontal cut, and sutured half of the flap to above the conjunctival arc and half to below. Blaskovic modified this technique and sutured to the episclera. In Terson's technique, however, Terson performed a vertical incision parallel to the lower border of the quadrilateral defect that resulted after the total excision of the pterygium, slid the flap upwards, and then sutured it. In Arlt's technique, Arlt totally excised the pterygium and closed the defect with the flap that he had slid from under. Czermark defined another technique; by performing paracorneal incisions above and below, Czermark created small flaps and sutured them together (1).
In 1985, after the study that Kenyon et al. (10) conducted on 17 cases, the use of conjunctival autografts became popular. In this study, Kenyon reported a relapse rate of 5.3%. After considering that the UV light-based limbal cell loss could cause pterygium formation, limbus has started to be added to the conjunctival autograph. This limboconjunctival autograft technique aims at inducing contact inhibition in the abnormal residual tissue, a rearranging of the limbal barrier with transplanted healthy limbal cells, and, as a result, construction of a barrier against the invasion of the cornea by conjunctiva by preventing fibrosis.
Ayala et al. (11) used bioadhesives in conjunctival autographs
and reported a relapse rate of 4.54%. Dupps et al. (12) reported in their study that in narrow-strip conjunctival autografts, 94.7% of the cases were successful. Luanratanakorn et al. (13) compared amniotic membrane and conjunctival autographs in their study, and in the primary pterygium group, the conjunctival autographs showed a 12.3% recurrence rate, whereas the amniotic group showed 25%, and in the relapse pterygia, the conjunctival autographs showed a 21.4% relapse rate, whereas amniotics showed 52.6%. In a comparative study consisting of four groups by Alpay et al. (14) , a bare sclera technique, bare sclera + mitomycin C, a conjunctival flap technique, and a conjunctival autograph technique were compared. The recurrence rate was observed as 38.09% in the bare sclera group, as 25% in the bare sclera + mit C group, as 33.3% in the conjunctival flap group, and as 33.3% in the conjunctival autograph group. Hall et al. (15) It is maintained that in high-risk groups, limbal transplantation is safer and more effective than conjunctival autograft transplantation in avoiding relapse in advanced and recurrent pterygium (23) .
In recent years, publications that mention the limbal stem cell deficiency theory in pterygium etiopathogenesis have been reported. Limbal stem cells prevent the invasion of the cornea by conjunctival epithelial cells by acting like a barrier and form the source of cornea epithelia. Furthermore, flaps hold on to where they are carried quicker than grafts do and thus wound healing occurs quicker. Based on this theory, we contemplated that if the flap was simultaneously limboconjunctival, it would reduce relapses even more, and hence, we applied this new technique of ours to 33 eyes. The two cases (6.1%) that relapsed were among the first patients that we applied the technique to. We maintain that the failure in these cases resulted from a lack of surgical experience.
Relapse rates in pterygium following limbal stem cell or limboconjunctival tissue transplantation vary between 0% and 14.6% (23) (24) (25) (26) (27) . Conjunctival autograph relapse rates vary between 0% and 33.3% in the literature (11-14, 28, 29) . Relapse rates after amniotic membrane coverage are reported to be between 3.0% and 40.9% (13, 27, 28, 30) . Relapse rate in pedunculated flaps is reported to be 10.7% and 0-33.3% in sliding flaps (Table 3) (14, 17, 18, (20) (21) (22) .
CONCLUSION
We maintain that the limboconjunctival sliding flap technique that we have developed is successful, safe, and effective because of its ease of use, non-obstruction of filtration surgery, and quicker application times compared with autografts, and it also has low relapse rates. However, large-scale, comparative, and longterm follow-up studies are needed.
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